A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
Abstract Background Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identif...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-021-01944-9 |
id |
doaj-3e9d83106553412db3cb4a7816951e8a |
---|---|
record_format |
Article |
spelling |
doaj-3e9d83106553412db3cb4a7816951e8a2021-08-15T11:29:56ZengBMCOrphanet Journal of Rare Diseases1750-11722021-08-011611910.1186/s13023-021-01944-9A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch modelAgnes Kocher0Mwidimi Ndosi1Kris Denhaerynck2Michael Simon3Andrew A. Dwyer4Oliver Distler5Kirsten Hoeper6Patrizia Künzler-Heule7Anthony C. Redmond8Peter M. Villiger9Ulrich A. Walker10Dunja Nicca11Institute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselSchool of Health and Social Wellbeing, University of the West of EnglandInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselBoston College, Connell School of NursingDepartment of Rheumatology, University Hospital Zurich, University of ZurichHannover Medical School, Department, Rheumatology and ImmunologyInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of LeedsDepartment of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of BernDepartment of Rheumatology, University Hospital BaselInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselAbstract Background Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified concerns. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL) is a 29-item tool validated in six languages. Previous evaluation of the German version revealed problems with dichotomous responses. This study aimed to revise the German SScQoL, extend the response structure, and evaluate content and construct validity, reliability and unidimensionality. Methods The instrument validation study involved revising the German SScQoL response structure, cognitive debriefing with patients and validation using Rasch analysis. The revised SScQoL was completed by Swiss-German-speaking patients with SSc within the Swiss MANagement Of Systemic Sclerosis (MANOSS) study. Rasch analysis was employed to test the validity, reliability and unidimensionality of the revised instrument. Results Based on cognitive debriefing with patients (n = 6) dichotomous items were extended to a polytomous 4-point response structure. A total of 78 patients completed the revised SScQoL. Initial analysis of the 29 items suggested the scale lacked fit to the model (χ2 = 51.224, df = 29, p = 0.007). Grouping items into five domains resulted in an adequate fit to the Rasch model (χ2 = 5.343, df = 5, p = 0.376) and unidimensionality (proportion of significant independent t tests: 0.045, 95% CI 0.016–0.114). Overall, the scale was well targeted, had high internal consistency (Person Separation Index, PSI = 0.931) and worked consistently in patients with different demographic and clinical characteristics. Conclusions The revised German SScQoL has a 4-point response structure and is a valid, reliable measure. Rasch analysis is useful for validating continuous response structure of quality of life measures. Further evaluation of measurement equivalence with other German-speaking cultures is required for multinational comparisons and data pooling.https://doi.org/10.1186/s13023-021-01944-9Health-related quality of lifeItem response theoryMethodologyPatient-centered carePatient reported outcome measuresRare diseases |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Agnes Kocher Mwidimi Ndosi Kris Denhaerynck Michael Simon Andrew A. Dwyer Oliver Distler Kirsten Hoeper Patrizia Künzler-Heule Anthony C. Redmond Peter M. Villiger Ulrich A. Walker Dunja Nicca |
spellingShingle |
Agnes Kocher Mwidimi Ndosi Kris Denhaerynck Michael Simon Andrew A. Dwyer Oliver Distler Kirsten Hoeper Patrizia Künzler-Heule Anthony C. Redmond Peter M. Villiger Ulrich A. Walker Dunja Nicca A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model Orphanet Journal of Rare Diseases Health-related quality of life Item response theory Methodology Patient-centered care Patient reported outcome measures Rare diseases |
author_facet |
Agnes Kocher Mwidimi Ndosi Kris Denhaerynck Michael Simon Andrew A. Dwyer Oliver Distler Kirsten Hoeper Patrizia Künzler-Heule Anthony C. Redmond Peter M. Villiger Ulrich A. Walker Dunja Nicca |
author_sort |
Agnes Kocher |
title |
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_short |
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_full |
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_fullStr |
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_full_unstemmed |
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model |
title_sort |
rare disease patient-reported outcome measure: revision and validation of the german version of the systemic sclerosis quality of life questionnaire (sscqol) using the rasch model |
publisher |
BMC |
series |
Orphanet Journal of Rare Diseases |
issn |
1750-1172 |
publishDate |
2021-08-01 |
description |
Abstract Background Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified concerns. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL) is a 29-item tool validated in six languages. Previous evaluation of the German version revealed problems with dichotomous responses. This study aimed to revise the German SScQoL, extend the response structure, and evaluate content and construct validity, reliability and unidimensionality. Methods The instrument validation study involved revising the German SScQoL response structure, cognitive debriefing with patients and validation using Rasch analysis. The revised SScQoL was completed by Swiss-German-speaking patients with SSc within the Swiss MANagement Of Systemic Sclerosis (MANOSS) study. Rasch analysis was employed to test the validity, reliability and unidimensionality of the revised instrument. Results Based on cognitive debriefing with patients (n = 6) dichotomous items were extended to a polytomous 4-point response structure. A total of 78 patients completed the revised SScQoL. Initial analysis of the 29 items suggested the scale lacked fit to the model (χ2 = 51.224, df = 29, p = 0.007). Grouping items into five domains resulted in an adequate fit to the Rasch model (χ2 = 5.343, df = 5, p = 0.376) and unidimensionality (proportion of significant independent t tests: 0.045, 95% CI 0.016–0.114). Overall, the scale was well targeted, had high internal consistency (Person Separation Index, PSI = 0.931) and worked consistently in patients with different demographic and clinical characteristics. Conclusions The revised German SScQoL has a 4-point response structure and is a valid, reliable measure. Rasch analysis is useful for validating continuous response structure of quality of life measures. Further evaluation of measurement equivalence with other German-speaking cultures is required for multinational comparisons and data pooling. |
topic |
Health-related quality of life Item response theory Methodology Patient-centered care Patient reported outcome measures Rare diseases |
url |
https://doi.org/10.1186/s13023-021-01944-9 |
work_keys_str_mv |
AT agneskocher ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT mwidimindosi ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT krisdenhaerynck ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT michaelsimon ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT andrewadwyer ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT oliverdistler ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT kirstenhoeper ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT patriziakunzlerheule ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT anthonycredmond ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT petermvilliger ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT ulrichawalker ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT dunjanicca ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT agneskocher rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT mwidimindosi rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT krisdenhaerynck rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT michaelsimon rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT andrewadwyer rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT oliverdistler rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT kirstenhoeper rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT patriziakunzlerheule rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT anthonycredmond rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT petermvilliger rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT ulrichawalker rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel AT dunjanicca rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel |
_version_ |
1721206726401720320 |